Arq Bras Cir Dig16 Aug 2025
Advanced tumor stage, location, and rare histological types predict poor disease-free survival in surgically treated esophageal cancer patients. Multimodal therapy significantly enhances survival in stage III cases. Notably, squamous cell carcinoma poses a higher locoregional recurrence risk while offering protection against distant metastases. These findings…
J Gastrointest Surg15 Aug 2025
A fully robotic, ultrasound-guided technique for organ-sparing resection of gastric gastrointestinal stromal tumors (GISTs) yields impressive results. In a cohort of 46 patients, the procedure demonstrated no intraoperative complications and a postoperative morbidity rate below 5%. All surgeries achieved R0 resection with a median follow-up…
Updates Surg14 Aug 2025
The synchroseal device outperformed conventional ultrasonic shears in robotic gastrectomy for gastric cancer, significantly reducing postoperative C-reactive protein (CRP) levels and serum amylase, alongside shorter operation times. In a study of 25 patients using synchroseal, these markers indicated reduced inflammation. While fewer lymph nodes (LNs)…
BJS Open13 Aug 2025
Postoperative complications significantly hinder recovery in oesophageal cancer surgeries. Pneumonia emerges as the top threat to survival, potentially leading to an 8.3% reduction in mortality if avoided. Anastomotic leaks drive reoperations and extended hospital stays, with impacts of 39.8% and 56.9%, respectively. Respiratory failure dominates…
Eur J Surg Oncol10 Aug 2025
A novel non-invasive diagnostic model integrating traditional Chinese medicine tongue features with machine learning shows significant potential for early gastric cancer detection. An analysis of 292 participants revealed distinct tongue characteristics associated with gastric cancer, including bluish-purple and cracked appearances. The Gradient Boosting Decision Tree…
JAMA Surg9 Aug 2025
The DESTINEX study reveals a revolutionary approach to early gastric cancer detection through a 17-microRNA signature. With an impressive diagnostic performance of 96.3% and 95.3% area under the curve (AUC) in training and validation cohorts, this method could significantly enhance screening practices. Notably, the 10-microRNA…
Scand J Gastroenterol9 Aug 2025
In a comprehensive review of 40 patients with grade 1-2 duodenal neuroendocrine tumors, endoscopic resection emerged as a viable first-line treatment option. Notably, ligation-assisted endoscopic mucosal resection achieved a remarkable 100% complete resection rate, with only one case of perforation successfully managed endoscopically. During a…
Ann Surg Oncol8 Aug 2025
A novel machine learning-driven surface-enhanced Raman spectroscopy (SERS) platform showcased remarkable diagnostic prowess in identifying peritoneal metastasis in gastric cancer patients. The PCA-LDA model achieved an accuracy of 95.7%, sensitivity of 87.0%, and specificity of 95.5%, all significantly outperforming traditional methods like exfoliative cytology and…
J Gastrointest Surg5 Aug 2025
Minimally invasive, ultrasound-guided robotic resections for gastric gastrointestinal stromal tumors (GISTs) demonstrate remarkable safety and efficacy. A study of 46 patients, primarily with challenging tumor locations, revealed no intraoperative complications or conversions to open surgery. The approach resulted in less than 5% postoperative morbidity and…
Surg Endosc1 Aug 2025
In a multicenter trial involving 50 adults with chronic gastroesophageal reflux disease (GERD), RefluxStop surgery demonstrated remarkable long-term outcomes over five years. The median GERD-Health-Related Quality of Life (GERD-HRQL) score improved by 90%, and 24-hour pH monitoring revealed a 90% reduction in acid exposure time.…